The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.90
Bid: 17.92
Ask: 18.00
Change: -0.50 (-2.72%)
Spread: 0.08 (0.446%)
Open: 18.20
High: 18.20
Low: 17.90
Prev. Close: 18.40
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notes Publication of Oeko-Institut Report

14 Jun 2016 07:00

RNS Number : 0712B
Nanoco Group PLC
14 June 2016
 

For immediate release

14 June 2016

 

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Notes Publication of Oeko-Institut Report

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, notes publication of the latest report sponsored by the European Commission on the use in Europe of quantum dots that contain the hazardous substance cadmium.

The report, prepared by the Oeko-Institut for the European Commission, is available at the following link: http://rohs.exemptions.oeko.info/fileadmin/user_upload/reports/20160602_Final_Report_RoHS_Pack_10_Cd_QDs_amended.pdf.

The report, entitled Assistance to the Commission on Technological Socio-Economic and Cost-Benefit Assessment Related to Exemptions from the Substance restrictions in Electrical and Electronic Equipment (RoHS Directive), recommends no exemption for the use of cadmium-containing quantum dots in lighting applications and a three year exemption to the Restriction of Hazardous Substances Directive (RoHS) to allow the use of cadmium-containing quantum dots in display products.

The report contains many apparent contradictions and anomalies when compared with the version prepared by the same consultancy and published in 2014. The display recommendation is in conflict with an overwhelming vote last year by Members of the European Parliament to ban the use of cadmium in quantum dots. MEPs voted 618-33 against an exemption for cadmium-containing quantum dots.

The recommendations in the Oeko-Institut report are not legally binding but form part of a lengthy process of consultation during which the report's findings will be evaluated by the European Commission, Member States and the European Parliament. This consultation will need to consider whether the use of cadmium can be justified as, to quote the report, "it is beyond the scientifically based assessment mandate of the exemption evaluation to conclude whether the use of a RoHS restricted substance to enable a certain function or property is an acceptable cost".

Michael Edelman, Nanoco's Chief Executive Officer, commented: "We are studying this report closely and will respond to it as we see appropriate. There is no doubt that the recommendation for a new exemption for displays is retrogressive as cadmium-free quantum dots are in large-scale commercial production and TVs that use cadmium-free quantum dots are widely available. It is difficult to appreciate why the recommendations in this new report contradict the recommendations made by the same consultancy in its 2014 report, particularly in the light of the commercial success of cadmium-free alternatives.

"Of prime importance, and irrespective of European legislation, is that display makers themselves are choosing cadmium-free because of their commitment to developing products with a long-term and sustainable future."

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

David Blain, Chief Financial Officer

Caroline Watson, Investor Relations Manager

cwatson@nanocotechnologies.com

 

Tel: + 44 (0) 7799 897357

Canaccord Genuity - Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Mark Whitmore

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Neil Patel

Richard Bootle

Steven Tredget

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nano-materials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, Nanoco has a non-exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company. Nanoco also has a strategy of direct sales in display and in its other target markets, including lighting.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMGMVMFKGVZZ
Date   Source Headline
9th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 20244:06 pmRNSTR-1: Notification of Major Holdings
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20243:02 pmRNSExercise of Deferred Bonus Options
18th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20241:56 pmRNSNotification of Major Holdings
17th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20244:10 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Apr 20247:00 amRNSResult of Tender Offer
28th Mar 202412:52 pmRNSGeneral Meeting - Voting Results
27th Mar 20247:00 amRNSInterim Results
11th Mar 202412:47 pmRNSPosting of Circular
11th Mar 20247:00 amRNSProposed return of up to £33.0 million
8th Feb 20247:00 amRNSHalf Year Trading Update
7th Feb 202411:23 amRNSDirector Declaration
24th Jan 20247:00 amRNSReceipt of Final Litigation Proceeds
23rd Jan 20244:02 pmRNSNotification Of Transactions By PDMR
16th Jan 20243:40 pmRNSDirector/PDMR Shareholding
15th Jan 20244:35 pmRNSHolding(s) in Company
12th Jan 20249:45 amRNSJoint Development Agreement with European Customer
22nd Dec 20237:00 amRNSAppointment of Financial Adviser and Joint Broker
21st Dec 202312:00 pmRNSAppointments of Non-Executive Directors
12th Dec 20239:35 amRNSBlocklisting six-monthly return
7th Dec 20233:23 pmRNSResult of AGM
7th Dec 20237:00 amRNSAGM Statement & Trading Update
15th Nov 20237:00 amRNSFirst ever commercial production order
13th Nov 20234:28 pmRNS2023 Annual Report and Notice of AGM
7th Nov 20237:00 amRNSJoint Development Agreement with Asian Customer
2nd Nov 20232:18 pmRNSHolding(s) in Company
17th Oct 20237:00 amRNSUnaudited Preliminary Results
10th Oct 20237:00 amRNSNotice of Results
3rd Oct 20234:32 pmRNSForeign Currency Hedge of Litigation Settlement
14th Aug 20233:58 pmRNSResult of Meeting
8th Aug 20237:00 amRNSTrading Update
7th Aug 20237:00 amRNSGlass Lewis recommends to support Nanoco’s Board
2nd Aug 20237:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.